A. Galid

1.6k citations
27 papers · 748 indexed · h-index 9

Impact in

  • Oncology top 5%
    • Bone health and treatments
    • Inflammatory Biomarkers in Disease Prognosis
    • HER2/EGFR in Cancer Research
    • Breast Cancer Treatment Studies

Papers in

    • Cancer Treatment and Pharmacology 8
    • HER2/EGFR in Cancer Research 5
    • Lung Cancer Research Studies 4
    • Breast Cancer Treatment Studies 8

A. Galid

25 papers receiving 728 citations

Peers

A. Galid
Comparison fields: 5 of 72
  • Oncology 519
  • Cancer Research 209
  • Orthopedics and Sports Medicine 113
  • Internal Medicine 29
  • Radiology, Nuclear Medicine and Imaging 155
Replace Matthias Geberth with:
Matthias Geberth Germany
Timothy P. Spiro United States
Rou Jiang China
Teodoro Sava Italy
Marie-Joëlle Kaiser Belgium
Constantina A. Pappa Greece
L.V.A.M. Beex Netherlands
Yingjie Shao China
Sara Donati Italy
Bartłomiej Tomasik Poland
A. Galid relative to Matthias Geberth Germany Matthias Geberth's profile →
Citations per field
00.5×5.7×
Matthias Geberth · 1×
Citations per year

Countries citing papers authored by A. Galid

Since Specialization
Citations

This map shows the geographic impact of A. Galid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Galid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Galid more than expected).

Fields of papers citing papers by A. Galid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Galid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Galid. The network helps show where A. Galid may publish in the future.

Co-authors

The 25 scholars most cited alongside A. Galid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Galid Line = papers co-authored together A. Galid links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2006249
2 2003133
3 201591
4 200680
5 200767
6 200430
7 201820
8 200413
9 19999
10 20198
11 20127
12 20046
13 19985
14 20115
15 20125
16 20154
17 20033
18 20193
19 20162
20 20222

About A. Galid

A. Galid is a scholar working on Oncology, Cancer Research, Biochemistry, Hematology and Internal Medicine, having authored 27 papers that have together received 748 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Breast Cancer Treatment Studies (8 papers), HER2/EGFR in Cancer Research (5 papers), Advanced Breast Cancer Therapies (5 papers), Estrogen and related hormone effects (5 papers), Lung Cancer Research Studies (4 papers), Iron Metabolism and Disorders (3 papers) and Erythropoietin and Anemia Treatment (3 papers). The work is most often cited by research in Oncology (519 citations), Cancer Research (209 citations), Orthopedics and Sports Medicine (113 citations), Internal Medicine (29 citations) and Radiology, Nuclear Medicine and Imaging (155 citations). A. Galid has collaborated with scholars based in Austria, United States and Switzerland. Frequent co-authors include Michael Gnant, R. Jakesz, Brigitte Mlineritsch, Marianne Schmid, Christian Menzel, G. Luschin-Ebengreuth, H. Hausmaninger, Margaretha Rudas, S. Grampp and Martina Mittlboeck. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Current Medical Research and Opinion, Cancer Research and Clinical & Experimental Metastasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026